Woodline Partners LP Alpine Immune Sciences, Inc. Transaction History

Woodline Partners LP

  • $9.97 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$17.75 - $41.6 $13.2 Million - $31 Million
-745,772 Reduced 74.57%
254,334 $10.1 Million
Q4 2023

Feb 14, 2024
SELL
$8.54 - $20.22 $330,250 - $781,927
-38,671 Reduced 3.72%
1,000,106 $19.1 Million
Q3 2023

Nov 14, 2023
BUY
$10.13 - $13.98 $8.12 Million - $11.2 Million
801,213 Added 337.26%
1,038,777 $11.9 Million
Q2 2023

Aug 14, 2023
BUY
$6.84 - $11.91 $1.62 Million - $2.83 Million
237,564 New
237,564 $2.44 Million

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email